Other Species / Isoforms
  C1orf52 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
C48
PAKSAGGCRNKAEKR
0 2
C1orf52 (human) PAKSAGGCRNKAEKR C48
C1orf52 (mouse) SAPTTGGrGKQAEKR R46-m1
C1orf52 (rat) PAPTTGGRGKQAEKR R47
S65-p
GPDELFRsVtRPAFL
0 1
C1orf52 (human) GPDELFRsVtRPAFL S65-p
C1orf52 (mouse) GPDELFRSVTRPAFL S63
C1orf52 (rat) GPDELFRSVTRPAFL S64
T67-p
DELFRsVtRPAFLyN
0 2
C1orf52 (human) DELFRsVtRPAFLyN T67-p
C1orf52 (mouse) DELFRSVTRPAFLYN T65
C1orf52 (rat) DELFRSVTRPAFLYP T66
Y73-p
VtRPAFLyNPLNkQI
0 6
C1orf52 (human) VtRPAFLyNPLNkQI Y73-p
C1orf52 (mouse) VTRPAFLYNPLNKQI Y71
C1orf52 (rat) VTRPAFLYPPKEFKI Y72
K78-ub
FLyNPLNkQIDWERH
0 2
C1orf52 (human) FLyNPLNkQIDWERH K78-ub
C1orf52 (mouse) FLYNPLNKQIDWERH K76
C1orf52 (rat) gap -
K101-ub
PKEFKIWksNyVPPP
0 1
C1orf52 (human) PKEFKIWksNyVPPP K101-ub
C1orf52 (mouse) PKEFKIWKSNCVPPP K99
C1orf52 (rat) PKEFKIWKSNCVPPP K81
S102-p
KEFKIWksNyVPPPE
0 1
C1orf52 (human) KEFKIWksNyVPPPE S102-p
C1orf52 (mouse) KEFKIWKSNCVPPPE S100
C1orf52 (rat) KEFKIWKSNCVPPPE S82
Y104-p
FKIWksNyVPPPETY
0 3
C1orf52 (human) FKIWksNyVPPPETY Y104-p
C1orf52 (mouse) FKIWKSNCVPPPETY C102
C1orf52 (rat) FKIWKSNCVPPPETY C84
T113-p
PPPETYTtEKKPPPP
0 1
C1orf52 (human) PPPETYTtEKKPPPP T113-p
C1orf52 (mouse) PPPETYTTEKKPPPP T111
C1orf52 (rat) PPPETYTAEKkPPPP A93
K116
ETYTtEKKPPPPELD
0 1
C1orf52 (human) ETYTtEKKPPPPELD K116
C1orf52 (mouse) ETYTTEKKPPPPELD K114
C1orf52 (rat) ETYTAEKkPPPPELD K96-ac
S129-p
LDMAIKWsNIyEDNG
0 2
C1orf52 (human) LDMAIKWsNIyEDNG S129-p
C1orf52 (mouse) LDMAIKWSNIYEDNG S127
C1orf52 (rat) LDMAIKWSNIYEDNG S109
Y132-p
AIKWsNIyEDNGDDA
0 53
C1orf52 (human) AIKWsNIyEDNGDDA Y132-p
C1orf52 (mouse) AIKWSNIYEDNGDDA Y130
C1orf52 (rat) AIKWSNIYEDNGDDA Y112
K144-ac
DDAPQNAkKARLLPE
0 22
C1orf52 (human) DDAPQNAkKARLLPE K144-ac
C1orf52 (mouse) DDAPQNAKKARLLPE K142
C1orf52 (rat) DDAPQNAkKARLLPE K124-ac
K144-ub
DDAPQNAkKARLLPE
0 1
C1orf52 (human) DDAPQNAkKARLLPE K144-ub
C1orf52 (mouse) DDAPQNAKKARLLPE K142
C1orf52 (rat) DDAPQNAKKARLLPE K124
T155-p
LLPEGEEtLEsDDEK
0 6
C1orf52 (human) LLPEGEEtLEsDDEK T155-p
C1orf52 (mouse) LLPEGEEtVEsDDDK T153-p
C1orf52 (rat) LLPEGEETVEsDDDR T135
S158-p
EGEEtLEsDDEKDEH
Upstream
0 64
Treatment
  • metastatic potential
  • PI-103
C1orf52 (human) EGEEtLEsDDEKDEH S158-p
C1orf52 (mouse) EGEEtVEsDDDKDER S156-p
C1orf52 (rat) EGEETVEsDDDRDER S138-p
K179-ac
VEPGEPAkKKK____
0 8
C1orf52 (human) VEPGEPAkKKK____ K179-ac
C1orf52 (mouse) VEPGEAAKKKK____ K177
C1orf52 (rat) VEPGEAAkKKK____ K159-ac